Mortality versus FEV1, KCO and CT lung density measured at baseline in the UK alpha-1-antitrypsin deficiency assessment programme

P. A. Dawkins, L. J. Dowson, P. J. Guest, R. A. Stockley (Birmingham, United Kingdom)

Source: Annual Congress 2001 - Respiratory structure and function in COPD
Session: Respiratory structure and function in COPD
Session type: Thematic Poster Session
Number: 661
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. A. Dawkins, L. J. Dowson, P. J. Guest, R. A. Stockley (Birmingham, United Kingdom). Mortality versus FEV1, KCO and CT lung density measured at baseline in the UK alpha-1-antitrypsin deficiency assessment programme. Eur Respir J 2001; 16: Suppl. 31, 661

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
CT scan derived emphysema scores correlate with spirometry and gas exchange but not acute exacerbation rates (AER) or COPD assessment test (CAT) in COPD subjects with and without alpha-1-antitrypsin (AAT) deficiency
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013


Correlation between annual change in health status and CT-derived lung density in subjects with alpha-1-antitrypsin deficiency
Source: Eur Respir J 2003; 22: Suppl. 45, 385s
Year: 2003

Changes in spirometry (FVC and FEV1) in a closed population of COPD patients using new standarized values for Mexican people
Source: Eur Respir J 2003; 22: Suppl. 45, 69s
Year: 2003

Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007


Prediction of all cause mortality in a population sample is improved by using FEV1 quotient
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005


Yearly progression of low lung attenuation area in low dose CT scan for aymptomatic current smokers with normal lung function or GOLD stage I COPD
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013

Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database
Source: Annual Congress 2011 - Lung and airway function
Year: 2011


Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1
Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function
Year: 2016


Measurement of lung function deterioration in COPD by V/P SPECT
Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception
Year: 2016

Prevalence of abnormal lung volumes, DLCO and chest HRCT in smokers with normal spirometry
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013

Targeted segmental volume reduction with vapor ablation in emphysema results in reduced RV and clinically meaningful improvement (CMI) in FEV1
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016

Impact of the use of a finite value of NO conductance on Hb in the interpretation of TLNO and TLCO transfer in homogenous groups of patients
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014


The relationship between peak expiratory flow rate (PEFR) and forced expiratroy volume in the first second (FEV1) at low levels of FEV1. Implications for the assessment of COPD (chronic obstructive pulmonary disease) in primary care
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002

Adherence rates to 2005 ATS/ERS test performance standards for spirometry, single-breath diffusing capacity (DLco), and lung volumes in a multi-center inhaled insulin study
Source: Annual Congress 2008 - Beyond spirometry: the skills behind lung function testing
Year: 2008


Prospective analysis of lung function in COPD patients – home monitoring of FEV1 and PEF (PIKO®1)
Source: Eur Respir J 2006; 28: Suppl. 50, 108s
Year: 2006

Flow-volume parameters in COPD related to extended measurements of lung volume, diffusion and resistance
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013


Lung Clearance Index (LCI) and diffusion capacity of the lung (DLCO) in children with rheumatic disease
Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases
Year: 2020


Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

Radiological prevalence of emphysema on low dose computed tomography(LDCT) in ever-smokers with a normal spirometry
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020


The ratio of inspiratory ΣRrs to expiratory ΣRrs measured by forced oscillation technique correlates with the parameters reflecting narrowing of small airway measured by spirometry in patients with mild to moderate COPD
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013